| IGF2 | Insulin-like growth factor II |
|---|---|
| IGF II/Man-6-P | Insulin-like growth factor II/mannose-6-phosphate |
| IGFBP-2 | Insulin-like growth factor binding protein 2 |
| IGFBP-4 | Insulin-like growth factor binding protein 4 |
| IGFBPs | Insulin-like growth factors and their binding proteins |
| insulin isophane suspension |
Intermediate-acting insulin with onset in 1/2 to 1 hr and a duration of 18 to 28 hr. SEE: insulin for table.
Ãâó:
|
|---|---|
| insulin lispro |
A synthetic insulin with a very rapid onset and short duration of action. Diabetic patients typically use it immediately before meals to prevent postprandial hyperglycemia. Its absorption is more rapid than regular insulin. It is
Ãâó:
|
| insulin protamine zinc suspension |
Long-acting insulin with onset in 6 to 8 hr and a duration of 30 to 36 hr. SEE: insulin for table.
Ãâó:
|
| insulin zinc extended suspension |
Long-acting insulin with onset in 5 to 8 hr and duration of more than 36 hr.
Ãâó:
|
| insulin zinc prompt suspension |
Fast-acting insulin with onset less than 1 hr and a duration of 12 to 16 hr.
Ãâó:
|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|